UNSPSC 51182102: Argipressin or vasopressin

This classification denotes antidiuretic hormones released by the neurohypophysis of all vertebrates (structure varies with species) to regulate water balance and osmolarity, most especially arginine vasopressin, which typically arises in the molecular formula C46H65N15O12S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Y87Y826H08, chemically known as 1-[19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[1-[(2-amino-2-oxoethyl)amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]pyrrolidine-2-carboxamide but generally known as vasopressin, which bears US NIH Compound Identifier 8230.

UNSPSC 51182102 Argipressin or vasopressin is a Commodity code under which state and local governments procure specific pharmaceutical products through cooperative purchasing vehicles. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, is the primary issuing body active under this code in recent solicitations. State and local agencies use MMCAP contracts to source generic multi-source pharmaceuticals and over-the-counter products for distribution across participating state and local government facilities. Vendors must meet rigorous compliance standards, including current Good Manufacturing Practices (cGMP) and Drug Supply Chain Security Act (DSCSA) certification, maintain contractual relationships with at least two of three authorized wholesalers (AmerisourceBergen Drug Corporation / Cencora, Cardinal Health 110 and 112, and Morris & Dickson Co., LLC), and carry comprehensive insurance including commercial general liability of $5,000,000 per occurrence and network security and privacy liability of $2,000,000. Products must be FDA-compliant with expiration dates of at least one year from manufacture and a minimum six-month shelf life.

MMCAP's geographic scope spans Minnesota and Oregon, with participating state and local government facilities across the alliance membership. A Request for Proposal (RFP) for MMCAP Generic Multi Source Pharmaceuticals and OTC Products (S1070000015802) posted January 20, 2026, with responses due March 26, 2026. Evaluation weighting prioritizes price competitiveness (75 percent) and fixed pricing for the contract term (10 percent), with the remaining weight distributed across compliance with administrative fee data format requirements, electronic data interchange capability, and agreement to a 3 percent administrative fee. Awarded vendors will become effective July 1, 2026, under a two-year initial contract term with optional extensions at MMCAP's discretion, with incumbent amendments aligning through June 30, 2028. Vendors submitting through the ePro procurement system must provide detailed product information including National Drug Codes, SKUs, UPCs, generic descriptions, strength, dosage form, trade names, packaging configurations, and manufacturing locations in designated Excel-to-CSV format.